On Monday, the PSX witnessed a sharp sell-off as the benchmark KSE-100 Index plunged, as investors remained wary due to ...
Pakistan State Oil (PSO) has proactively optimized its operations in response to the evolving geopolitical environment, to ...
Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...
Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Air Charter Scotland have been operating the route since January 14 and have recently introduced an 18-seat Jetstream 32 ...
ORKA-001 EVERLAST-A 16-week data now expected in 2Q 2026 following rapid enrollment, with longer-term follow-up data expected in 2H ...
US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...
Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval ...
The Scottish government is to provide up to £663,000 to help fund subsidised flights between Wick and Aberdeen until 14 ...
A white paper published by the Office of the Principal Scientific Advisory (PSO) on Sunday threw its weight behind the ...
Workiva delivers cloud-based compliance and data integration solutions to corporations, government agencies, and educational institutions.